Merus annonce la présentation des données cliniques de phase 1 sur le MCLA-158 lors du Symposium sur les cancers gastro-intestinaux 2021 de l’American Society of Clinical Oncology (ASCO)

NEXT STORY
New Children’s Chapter Book Promotes Benefits of Practicing Mental and Physical Activities
PREV STORY
Grokker Brings Workplace Wellbeing Insights to NRF 2021 Virtual Conference
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Devonian Health Group announces the commercial launch of the Purgenesis(TM) Anti-aging treatment at the Canadian Dermatology Association’s annual conference

First launch of the Purgenesis™ skin care lineFirst and only product line distributed by ...

author_avatar
NASDAQ Market News

Kessler Topaz Meltzer & Check, LLP: Securities Fraud Class Action Filed Against Novavax, Inc. with Lead Plaintiff Deadline Approaching

author_avatar
NASDAQ Market News

Cellectar Biosciences to Host Conference Call on November 10, 2017 to Report Third Quarter 2017 Financial Results and Corporate Performance

MADISON, Wis., Nov. 02, 2017 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq:CLRB), (the “company”), ...

author_avatar
NASDAQ Market News